Neuren Pharmaceuticals | NEU - Cash And Equivalent

Stock Price
12.35
Daily Change
-0.44 -3.44%
Monthly
-1.04%
Yearly
-2.22%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD5.91M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 162.64M 22.2M Mar/2026
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Avita Medical AUD 10.24M 1.98M Dec/2025
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Genetic Signatures AUD 7.47M 33.32M Jun/2025
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
Medical Developments International AUD 17.84M 219K Jun/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Organon & Co USD 1.12B 542M Mar/2026
Paradigm Biopharmaceuticals AUD 16.82M 1M Jun/2025
PYC Therapeutics AUD 153.05M 103.8M Jun/2025
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Telix Pharmaceuticals AUD 207.16M 503.19M Jun/2025
Viatris USD 1.8B 481.8M Mar/2026
Xeris Pharmaceuticals USD 111.75M 708K Mar/2026